Why LIMS Implementations Fail
Seven patterns that play out repeatedly across genomics, molecular diagnostics, and clinical lab environments. The culprit is almost never the technology.
Read →Laboratory Technical Debt
High-throughput platforms sitting well below capacity. Leadership won’t approve expansion. The overhead per sample makes growth uneconomical. How technical debt accumulates, and the path out.
Read →Why End-to-End Workflow Projects Stall — and How to Fix It
How to right-size your E2E architecture for where you're headed, find your rate-limiting steps before you buy anything, and get your lab funded as the investment it is.
Read →The Costs Labs Miss Before Buying a Molecular Platform
The seven costs labs miss before they buy, and how to model true cost of adoption.
Read →The Reimbursement Ceiling
A molecular lab doesn’t set its own price. CLFS and payer contracts set the ceiling; cost per reportable is the only lever you control. How to find which lines go underwater before a rate takes effect.
Read →When Compromise Becomes Infrastructure
Every lab accepts compromises that fade into the operational background. Years later, they’re not decisions anymore; they’re infrastructure. How growing labs name and quantify what they stopped seeing.
Read →Cloud vs. On-Prem: Why Your 2020 Answer May Be Wrong in 2026
The cloud vs. on-prem analysis that produced clean answers from 2017–2023 no longer holds without revisiting. A structured framework for lab leadership re-evaluating deployment strategy with current inputs.
Read →Lab Readiness Quick-Check
A 34-question interactive check across 10 domains, about 8 minutes, free. Know your gaps before you commit to a platform.
Open →LIMS Evaluation Scorecard
Score and compare LIMS vendors across deployment, integration, no-code capability, custom code exposure, workflow fit, and post-go-live support, built from real RFP experience on both sides of the table. Free.
Open →Deployment Discovery Framework
A 24-question interactive framework across 8 factors, about 6 minutes, free. Produces a directional hypothesis (cloud, hybrid, or on-prem) for your leadership team to pressure-test. Not a verdict.
Open →Twelve Years Across Every Layer of the Molecular Workflow
I started my career at the end of the genomics chain and, twelve years later, owned the whole thing. HelixWrks exists to build for the problems I spent those years watching go unsolved.
Read →